94 related articles for article (PubMed ID: 36576530)
1. Comparison of PD-L1 expression in squamous cell cancer of unknown primary and oropharyngeal squamous cell carcinoma.
Schmidl B; Voßenkämper KA; Stark L; Boxberg M; Stögbauer F; Feigl K; Winter C; Pickhard A; Wollenberg B; Wirth M
Eur Arch Otorhinolaryngol; 2023 Apr; 280(4):1991-1997. PubMed ID: 36576530
[TBL] [Abstract][Full Text] [Related]
2. A comparison between p16-positive head and neck cancer of unknown primary (HPV-HNCUP) and oropharyngeal squamous cell carcinoma (HPV-OPSCC): are they the same disease?
Balk M; Rupp R; Sievert M; Mantsopoulos K; Allner M; Grundtner P; Mueller SK; Eckstein M; Iro H; Hecht M; Gostian AO
Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5489-5497. PubMed ID: 37505261
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Significance of the Microenvironment in Human Papillomavirus Oropharyngeal Carcinoma: A Systematic Review.
Baudouin R; Hans S; Lisan Q; Morin B; Adimi Y; Martin J; Lechien JR; Tartour E; Badoual C
Laryngoscope; 2024 Apr; 134(4):1507-1516. PubMed ID: 37642393
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy in HPV-Related Oropharyngeal Cancers.
Roof L; Yilmaz E
Curr Treat Options Oncol; 2023 Mar; 24(3):170-183. PubMed ID: 36719604
[TBL] [Abstract][Full Text] [Related]
5. M1 macrophages induce PD-L1
Wu J; Pang X; Yang X; Zhang M; Chen B; Fan H; Wang H; Yu X; Tang Y; Liang X
J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38148114
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus circulating tumor DNA: a diagnostic tool in squamous cell carcinoma of unknown primary-a pilot study.
Kais A; Santiago SP; Han PC; Clump DA; Stokes WA; Fancy T; Cui R; Martin E; Turner MT
Front Oncol; 2024; 14():1376595. PubMed ID: 38628671
[TBL] [Abstract][Full Text] [Related]
7. Detection of antibody subclasses IgA, IgM and IgG against HPV L1 in HPV-positive oropharyngeal squamous cell carcinoma patients: a pilot study.
Weiland T; Zgubic J; Brcic L; Thurnher D
Eur Arch Otorhinolaryngol; 2024 May; 281(5):2637-2644. PubMed ID: 38441604
[TBL] [Abstract][Full Text] [Related]
8. Human Immunodeficiency Virus Is Associated With Poor Overall Survival Among Patients With Head and Neck Cancer.
Salahuddin S; Cohen O; Wu M; Perez Irizarry J; Vega T; Gan G; Deng Y; Isaeva N; Prasad M; Schalper KA; Mehra S; Yarbrough WG; Emu B
Clin Infect Dis; 2023 Apr; 76(8):1449-1458. PubMed ID: 36520995
[TBL] [Abstract][Full Text] [Related]
9. Dynamic Up-Regulation of PD-L1 in the Progression of Oral Squamous Cell Carcinoma.
Steen S; Semmelmayer K; Flechtenmacher C; Hoffmann J; Freier K; Horn D; Hess J; Freudlsperger C; Moratin J
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003576
[TBL] [Abstract][Full Text] [Related]
10. Assessing PD-L1 Expression in Head and Neck Squamous Cell Carcinoma: Trials and Tribulations.
Bill R; Faquin WC; Pai SI
Head Neck Pathol; 2023 Dec; 17(4):969-975. PubMed ID: 37930471
[TBL] [Abstract][Full Text] [Related]
11. Recurrent Oropharyngeal Squamous Cell Carcinomas Maintain Anti-tumor Immunity and Multinucleation Levels Following Completion of Radiation.
Castro P; Corredor G; Koyuncu C; Nordstrom LA; Tiji M; Leavitt T; Lewis JS; Madabhushi A; Frederick MJ; Sandulache VC
Head Neck Pathol; 2023 Dec; 17(4):952-960. PubMed ID: 37995073
[TBL] [Abstract][Full Text] [Related]
12. Increased PD-L1 and p16 expression are common in oropharyngeal squamous cell carcinoma.
Shestakova A; Tarabay J; Burtsev A; Ibe I; Kim J; Chandan V; Armstrong WB; Tjoson T; Wang B
Future Sci OA; 2021 Oct; 7(9):FSO768. PubMed ID: 34737892
[TBL] [Abstract][Full Text] [Related]
13. Local Treatment Efficacy for Single-Area Squamous Cell Carcinoma of the Unknown Primary Site.
Kurita T; Yunokawa M; Tanaka Y; Okamoto K; Kanno M; Fusegi A; Omi M; Netsu S; Nomura H; Tonooka A; Kanao H
Curr Oncol; 2023 Oct; 30(10):9327-9334. PubMed ID: 37887574
[TBL] [Abstract][Full Text] [Related]
14. Mu and Kappa opioid receptor immunolabeling indicates the prognosis of oropharyngeal squamous cell carcinoma: A cross-sectional observational study.
Dantas TS; Silva PGB; de Oliveira Filho OV; Magalhães IA; Alves APNN; Cunha MDPSS; Mota MRL; Leitão RFC; Sousa FB
J Stomatol Oral Maxillofac Surg; 2023 Dec; 124(6S):101554. PubMed ID: 37453566
[TBL] [Abstract][Full Text] [Related]
15. Extracting interpretable features for pathologists using weakly supervised learning to predict p16 expression in oropharyngeal cancer.
Adachi M; Taki T; Sakamoto N; Kojima M; Hirao A; Matsuura K; Hayashi R; Tabuchi K; Ishikawa S; Ishii G; Sakashita S
Sci Rep; 2024 Feb; 14(1):4506. PubMed ID: 38402356
[TBL] [Abstract][Full Text] [Related]
16. Recurrent oropharyngeal squamous cell carcinomas maintain anti-tumor immunity and multinucleation levels following completion of radiation.
Castro P; Corredor G; Koyuncu C; Nordstrom LA; Tiji M; Leavitt T; Lewis JS; Madabhushi A; Frederick MJ; Sandulache VC
Res Sq; 2023 Aug; ():. PubMed ID: 37674722
[TBL] [Abstract][Full Text] [Related]
17. Editorial for "In Vivo Microstructure Imaging in Oropharyngeal Squamous Cell Carcinoma Using the Random Walk With Barriers Model".
Iima M; Yamamoto A
J Magn Reson Imaging; 2024 Mar; 59(3):939-940. PubMed ID: 37452628
[No Abstract] [Full Text] [Related]
18. Comments on the article titled "Factors associated with unknown primary status in head and neck squamous cell carcinoma": Is the N status the overlooked elephant in the room?
Fancello G; Jiang S; Licci G; Gallo O
Oral Oncol; 2024 Apr; 151():106727. PubMed ID: 38387260
[No Abstract] [Full Text] [Related]
19. Tumor-stroma contact ratio - a novel predictive factor for tumor response to chemoradiotherapy in locally advanced oropharyngeal cancer.
Kaufmann J; Haist M; Kur IM; Zimmer S; Hagemann J; Matthias C; Grabbe S; Schmidberger H; Weigert A; Mayer A
Transl Oncol; 2024 Jun; 46():102019. PubMed ID: 38833784
[TBL] [Abstract][Full Text] [Related]
20. Deep spatial-omics analysis of Head & Neck carcinomas provides alternative therapeutic targets and rationale for treatment failure.
Causer A; Tan X; Lu X; Moseley P; Teoh SM; Molotkov N; McGrath M; Kim T; Simpson PT; Perry C; Frazer IH; Panizza B; Ladwa R; Nguyen Q; Gonzalez-Cruz JL
NPJ Precis Oncol; 2023 Sep; 7(1):89. PubMed ID: 37704757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
